Granisetron for Nausea and Vomiting (Kytril, Sancuso)

Authored by Dr. Sarah Thompson, Reviewed on January 13, 2026

Granisetron is an antiemetic medication belonging to the 5-HT3 receptor antagonist class, specifically designed to prevent nausea and vomiting associated with cancer treatments and surgery. It works by blocking serotonin receptors in the gut and central nervous system, which are key triggers for these symptoms.

About granisetron

Granisetron, available under brand names such as

Kytril

and

Sancuso

, is highly effective in controlling acute and delayed nausea and vomiting. It is commonly prescribed for patients undergoing moderately or highly emetogenic chemotherapy, radiation therapy to the upper abdomen or total body, and postoperative nausea following surgery. Unlike some other antiemetics, granisetron has a favorable safety profile with minimal sedation.

The medication comes in multiple forms to suit different needs: oral tablets, oral solution, intravenous injection, and transdermal patch (Sancuso), allowing flexibility based on patient preference and treatment setting. Clinical studies demonstrate that granisetron significantly reduces the incidence of vomiting episodes, improving quality of life during cancer treatment.

Before taking granisetron

Allergy warning

Do not use granisetron if you have a known allergy to granisetron or other 5-HT3 antagonists like ondansetron (Zofran), dolasetron (Anzemet), or palonosetron (Aloxi). Allergic reactions can be severe, including anaphylaxis with symptoms like rash, hives, swelling, difficulty breathing, or low blood pressure. Seek immediate medical help if these occur.

Medical conditions

• Heart conditions: Granisetron may prolong the QT interval, increasing risk of irregular heartbeats (arrhythmia), fainting, or sudden cardiac events, especially in those with heart disease, heart failure, low potassium/magnesium, or congenital long QT syndrome.
• Gastrointestinal issues: Use caution with bowel obstruction, gastric distension, or recent abdominal surgery, as it may mask symptoms.
• Liver problems: Dose adjustments may be needed; monitor for signs like jaundice, dark urine, or abdominal pain.
• Electrolyte imbalance: Correct before starting treatment.

Other medicines

Inform your doctor about all medications, as interactions can occur:

• Serotonin-affecting drugs: Risk of serotonin syndrome (confusion, fever, tremors) with antidepressants (SSRIs, SNRIs), tramadol, lithium, or St. John’s Wort.
• QT-prolonging drugs: Increases heart rhythm risks with certain antibiotics, antifungals, or antiarrhythmics.
• Other antiemetics: May enhance effects.

Pregnancy and breastfeeding

Granisetron is category B in pregnancy (no proven risk in animal studies, but limited human data); use only if benefits outweigh risks. It passes into breast milk; breastfeeding is not recommended during treatment and for 48 hours after. Consult your healthcare provider.

How and when to take granisetron

Dosage

Dosage varies by indication, form, and patient factors (age, weight, emetogenicity). Always follow your doctor’s instructions.

Form	Indication	Typical Adult Dose	Timing
Oral tablet/solution (1 mg)	Chemotherapy	1-2 mg	1 hour before chemo, may repeat 12 hours later
IV injection (1 mg)	Chemotherapy/radiation	1 mg	30 min before treatment
Transdermal patch (Sancuso, 3.1 mg/24h)	Chemotherapy	1 patch	Apply 24-48 hours before chemo, wear 7 days
Pediatric (>2 yrs, >30kg)	Chemotherapy	0.02 mg/kg (max 1 mg) oral/IV	Before treatment

Administration tips

• Take oral forms with or without food.
• For patch: Apply to clean, dry, intact skin on upper arm; do not cut; rotate sites; fold and discard after use.
• IV: Administered by healthcare professional.
• Miss a dose? Take as soon as remembered unless near next dose; do not double.

Side effects of granisetron

Most side effects are mild and transient. Common ones affect over 10% of users.

Common side effects

• Headache
• Constipation or diarrhea
• Abdominal pain or indigestion
• Drowsiness or weakness/fatigue
• Unusual tiredness

Serious side effects

Seek immediate medical attention for:

• Serotonin syndrome: Agitation, hallucinations, fever, sweating, muscle rigidity, tremors.
• Heart issues: Fast/irregular heartbeat, fainting, chest pain, dizziness.
• Allergic reaction: Rash, hives, swelling, breathing difficulty, anaphylaxis.
• Gastrointestinal: Severe constipation, stomach pain/swelling (may indicate obstruction).
• Liver: Yellowing skin/eyes, dark urine, nausea.

Rare effects include blurred vision, fever, nervousness, sleep issues.

Overdose

Symptoms: Headache, palpitations, hypertension. Seek emergency care; no specific antidote.

How to cope with side effects of granisetron

• Headache: Rest, hydrate, use over-the-counter pain relievers if approved.
• Constipation: Increase fiber, fluids, exercise; use stool softeners.
• Drowsiness: Avoid driving/machinery until effects known.
• QT prolongation risk: Regular ECG monitoring if at risk.
• What to avoid: Alcohol (increases drowsiness), serotonin drugs without advice.

Pregnancy and breastfeeding with granisetron

Limited data; animal studies show no fetal harm. Discuss risks/benefits with your doctor. Avoid breastfeeding during and 48 hours post-dose due to excretion in milk.

Common questions about granisetron

How quickly does granisetron work?

Within 30-60 minutes for oral/IV; patch peaks in 48 hours.

Can I drink alcohol with granisetron?

Avoid, as it worsens drowsiness and dizziness.

Does granisetron cause drowsiness?

Yes, occasionally; monitor alertness.

Is granisetron safe for children?

Yes, for ages 2+ in chemo settings; dose by weight.

How long do I wear the Sancuso patch?

Up to 7 days or until chemo cycle ends.

Can granisetron be used for motion sickness?

No, primarily for chemo/radiation/post-op.

Alternatives to granisetron

Drug	Class	Key Uses
Ondansetron (Zofran)	5-HT3 antagonist	Chemo, post-op nausea
Palonosetron (Aloxi)	5-HT3 antagonist	Longer-acting for chemo
Aprepitant (Emend)	NK1 antagonist	Highly emetogenic chemo (combo)
Dexamethasone	Corticosteroid	Adjunct therapy

Choice depends on emetogenic risk, patient factors. Combinations often used for high-risk cases.